Form 4: DaVita Director Acquires Common Stock

DaVita Inc. Director Pamela M. Arway acquired 411 shares of common stock on November 15, 2025, increasing her direct beneficial ownership to 26,363 shares.

Summary

• Pamela M. Arway, a Director of DaVita Inc. (DVA), acquired 411 shares of common stock.
• The transaction occurred on November 15, 2025, at a price of $0 per share, indicating a grant or award.
• Following this acquisition, Ms. Arway directly beneficially owns a total of 26,363 shares of DaVita Inc. common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The sentiment is mildly positive due to a director increasing their stake in the company, even if through a grant. This generally signals confidence and alignment of interests, though the small size of the acquisition limits its overall impact on sentiment.

Positives

• A director's acquisition of company stock, even if a grant, generally signals alignment of interests between management and shareholders.
• The transaction was executed under a Rule 10b5-1 plan, indicating a pre-planned and non-opportunistic acquisition.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction is a routine disclosure for publicly traded companies and does not directly provide insights into broader industry trends or competitive landscape. It reflects an individual director's equity holdings and compensation structure within the healthcare services sector, specifically kidney care.

Related Party Transactions

• Pamela M. Arway, a Director of DaVita Inc., acquired 411 shares of the company's common stock, which constitutes an insider transaction.

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive signal, indicating management's continued commitment and belief in the company's future prospects.

Key Dates

Keywords

DaVita Inc., DVA, Insider Transaction, Form 4, Stock Acquisition, Director, Corporate Governance, Rule 10b5-1